Brandon M. Nathan

Brandon M. Nathan

Pediatric Endocrinology
303 E Nicollet Blvd
Suite 372
Burnsville, MN 55337

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications

C-Peptide Provides Critical Contextual Insight Into Elevated Glucose Values During Progression to Type 1 Diabetes.

C-Peptide Provides Critical Contextual Insight Into Elevated Glucose Values During Progression to Type 1 Diabetes.

Journal: Diabetes care
Published: January 15, 2026

Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 Diabetes.

Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 Diabetes.

Journal: Diabetes
Published: September 02, 2025

Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression.

Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression.

Journal: Diabetes
Published: August 01, 2025

Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval.

Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval.

Journal: Diabetes
Published: March 28, 2025

Personalized Hemoglobin A1c Shows Better Correlation with Mean Glucose than Laboratory Hemoglobin A1c in Ugandan Youth with Type 1 Diabetes, but Mean Glucose Is Not Clinically Useful in This Population Due to Extreme Glucose Variability.

Personalized Hemoglobin A1c Shows Better Correlation with Mean Glucose than Laboratory Hemoglobin A1c in Ugandan Youth with Type 1 Diabetes, but Mean Glucose Is Not Clinically Useful in This Population Due to Extreme Glucose Variability.

Journal: Diabetes technology & therapeutics
Published: March 20, 2025

A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive Cohorts.

A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive Cohorts.

Journal: Diabetes technology & therapeutics
Published: January 06, 2025

Type 1 Diabetes TrialNet: Leading the Charge in Disease Prediction, Prevention, and Immunotherapeutic Mechanistic Understanding.

Type 1 Diabetes TrialNet: Leading the Charge in Disease Prediction, Prevention, and Immunotherapeutic Mechanistic Understanding.

Journal: Diabetes care
Published: December 31, 2024

IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes.

IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes.

Journal: Diabetologia
Published: July 22, 2024

Insulin-like growth factor-1 and insulin-like growth factor binding protein-3 as early predictors of growth, body composition, and neurodevelopment in preterm infants.

Insulin-like growth factor-1 and insulin-like growth factor binding protein-3 as early predictors of growth, body composition, and neurodevelopment in preterm infants.

Journal: Journal of perinatology : official journal of the California Perinatal Association
Published: October 11, 2023

Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk Individuals.

Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk Individuals.

Journal: The Journal of clinical endocrinology and metabolism
Published: September 20, 2023

An exploratory study of clinical factors associated with IGF-1 and IGFBP-3 in preterm infants.

An exploratory study of clinical factors associated with IGF-1 and IGFBP-3 in preterm infants.

Journal: Pediatric research
Published: May 04, 2023

Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies.

Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies.

Journal: Diabetes care
Published: November 17, 2022
Showing 1-12 of 57

Last Updated: 09/26/2026